Off-Label Convictions Of Device Execs Could Impact Pharma Sales Reps

Jury acquits former executives from J&J's Acclarent division of felony charges but convicts them on misdemeanor counts for marketing a sinus dilation device for use with a steroid; sales reps statements showed intended use.

Gavel_1200x675

The government's criminal complaint against two former medical device executives for marketing a device in combination with a drug could have an impact on the pharmaceutical industry and the way sales reps describe how products are intended to be used.

A federal jury in Boston found former Acclarent Inc. CEO William Facteau and former vice president of sales Patrick...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet